COLL vs DOW · P/E 17, rev $181.9M vs P/E 74, rev $42.96B
Collegium Pharmaceutical Inc (COLL) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Dow Inc (DOW) is a chemicals company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the COLL and DOW stock pages for the full models.
Not investment advice.